Digital Therapeutics startup Wundrsight has successfully raised $400K in a seed funding round led by Inflection Point Ventures (IPV). The round also saw participation from Social Alpha and several angel investors. This funding will help Wundrsight expand its network of hospital and clinic partnerships across India and accelerate the development of its Virtual Reality (VR)–based mental health solutions.
First in India: VR and AI-Based Therapy Platform
Founded in 2022, Wundrsight is India’s first company to build a Virtual Reality (VR) and AI-based therapy platform for mental healthcare management. The startup focuses on digitizing and standardizing mental health therapy through immersive VR technology, making care more accessible, effective, and personalized for conditions such as Substance Use Disorders, OCD, Anxiety, Phobia, Autism, and Dementia. Their innovative approach has earned backing from Meta, DLabs at Indian School of Business, IIT Mandi Catalyst, NASSCOM, and others.
Expert Leadership Driving Innovation
Raunak Swarnkar, Co-founder and CEO of Wundrsight, brings over 5 years of experience in AI/ML, B2B SaaS, and medical devices, having previously worked at TCS R&D, IBM, and RedSeer Consulting. Nishtha Budhiraja, Co-founder and Chief Medical Officer, is a psychologist with over 10 years of clinical experience and has worked with more than 5000 patients. Together, they aim to address inefficiencies in delivering high-quality mental healthcare, leveraging technology to solve these challenges.
Addressing the Mental Health Crisis
Vikram Ramasubramanian, Partner, Inflection Point Ventures says, “The mental health crisis is more alarming than ever; solving it with just traditional methods is often limited to accessibility, personalized treatment, and engagement. Many people start therapy but frequently drop off due to ineffective retention and engagement strategies. Wundrsight is at the forefront of addressing these issues by bringing in digital therapeutic and mixed reality technology like Virtual Reality to create personalized, immersive, and effective mental health care experiences. VR augments current solutions, helping to retain and engage users more effectively, ensuring they achieve their results. At IPV, we believe in Wundrsight’s vision to make mental wellness accessible to all through technological innovation.”
Proven Success in VR Therapy
Wundrsight’s VR solutions have already made a significant impact by reducing therapy session times by up to 30%, resulting in better patient outcomes and cost efficiency. The startup uses evidence-based practices and holds key certifications, including CDSCO Registration, ISO certifications, and CTRI-registered clinical trials.
Currently operating in three metro cities, Wundrsight has secured contracts with over five hospitals and is working on additional partnerships with leading private and government hospitals. Their suite of six VR therapy products has successfully treated more than 1000 patients across a variety of mental health conditions.
Expanding Reach and Future Plans
Wundrsight’s VR-based solutions aim to not only reduce reliance on medication but also improve clinician efficiency. Co-founder Raunak Swarnkar highlighted the importance of the current moment in mental healthcare, noting the increasing regulatory support for software-based medical devices. He said, “We’re at a pivotal moment in mental health care, especially now as innovative software-based medical devices are getting regulatory approvals for prescriptions. “Hospitals and clinics globally face immense pressure to provide high-quality, scalable mental health services despite a shortage of clinicians. Our VR-based solutions not only reduce the need for medication but also enhance clinician efficiency, allowing for safe, standardized and effective treatments. This funding will help us expand our reach and impact in India and APAC. We look forward to entering the US market next where VR therapy has received CPT codes for reimbursement from insurance providers.”
With plans to expand further into India and the APAC region, Wundrsight is also eyeing the US market, where VR therapy has received CPT codes for insurance reimbursement.
A Growing Mental Health Market in India
The mental health sector in India is poised for significant growth, with the market projected to reach USD 62.86 billion by 2032, up from USD 6.89 billion in 2023, growing at a CAGR of 28.16%.
Wundrsight’s pioneering work in VR therapy positions the company to be a major player in this rapidly expanding market, delivering innovative, scalable solutions to meet the rising demand for mental health care.
Also read – Medront Datalabs Raises INR 1.06 Crore in Pre-Seed Round Led by Inflection Point Ventures
Join our WhatsApp News Channel for quick updates – FYI9 News WhatsApp Channel
